Compass Therapeutics Inc. (CMPX) — Defensive Interval Ratio
Compass Therapeutics Inc. (CMPX) has a Defensive Interval Ratio of 3269 days as of June 2026. Defensive assets of $144.43 Million (cash $-, short-term investments $144.43 Million, receivables $-) cover 3269 days of daily cash needs of $44.19K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Compass Therapeutics Inc. Defensive Interval Ratio (2021–2025)
This chart shows how Compass Therapeutics Inc.'s Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 3269 days, meaning defensive assets of $144.43 Million can fund 3269 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Compass Therapeutics Inc..
Annual Defensive Interval Ratio for Compass Therapeutics Inc. (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Compass Therapeutics Inc. from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is Compass Therapeutics Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4658 days | $178.26 Million | $38.27K/day | $- | $178.26 Million | ▲ +1234 days |
| 2024 | 3424 days | $83.24 Million | $24.31K/day | $- | $83.24 Million | ▼ -2576 days |
| 2023 | 6000 days | $128.23 Million | $21.37K/day | $- | $128.23 Million | ▲ +2569 days |
| 2022 | 3431 days | $151.98 Million | $44.30K/day | $- | $151.66 Million | ▲ +3431 days |
| 2021 | 0 days | $0.00 | $29.13K/day | $- | $0.00 | — |